Patents by Inventor Steven John PASCOE

Steven John PASCOE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLUTICASONE FUROATE IN THE TREATMENT OF COPD
    Publication number: 20210205331
    Abstract: The present invention relates to a method of reducing the rate of decline in lung function in a human patient with COPD, wherein the human patient having COPD has a blood eosinophil count of ?150 cells/?L, and further wherein the method comprises administering to the patient an inhaled pharmaceutical product comprising fluticasone furoate.
    Type: Application
    Filed: March 18, 2021
    Publication date: July 8, 2021
    Inventors: Neil Christopher BARNES, Steven John Pascoe
  • Fluticasone furoate in the treatment of COPD
    Patent number: 10987363
    Abstract: The present invention relates to pharmaceutical products comprising fluticasone furoate for use in the treatment of COPD patients, particularly a subgroup of COPD patients that through analysis have been identified as possessing an eosinophil blood count of ?150 cells/?l. The present invention is further directed to methods for treating a patient with COPD which methods include identifying a patient that will respond to treatment and administering a pharmaceutical product of the present invention comprising fluticasone furoate to said patient.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: April 27, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Neil Christopher Barnes, Steven John Pascoe
  • FLUTICASONE FUROATE IN THE TREATMENT OF COPD
    Publication number: 20170189424
    Abstract: The present invention relates to pharmaceutical products comprising fluticasone furoate for use in the treatment of COPD patients, particularly a subgroup of COPD patients that through analysis have been identified as possessing an eosinophil blood count of?150 cells/W. The present invention is further directed to methods for treating a patient with COPD which methods include identifying a patient that will respond to treatment and administering a pharmaceutical product of the present invention comprising fluticasone furoate to said patient.
    Type: Application
    Filed: May 27, 2015
    Publication date: July 6, 2017
    Inventors: Neil Christopher BARNES, Steven John PASCOE